))
Why We Can't Stop Talking About Women's Health
Manage episode 496500405 series 3653997
Content provided by Melissa Gundling D'Elia and Melissa D'Elia. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Melissa Gundling D'Elia and Melissa D'Elia or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Her House: Built for Women's Health is all about engaging and encouraging women to be proactive advocates in their healthcare experience. We strive to celebrate leaders and care providers who are building solutions for the betterment of women's health.
Did you know?
Women weren’t required to be included in U.S. clinical trials until 1993.
That means decades of medical research was built primarily on male biology.
Women’s bodies have been underrepresented in basic research.
In animal studies, male mice were often the default — despite sex differences that could affect outcomes.
Sex-specific analysis and dosing has historically been rare in drug approvals.
Even though women metabolize many medications differently than men.
Thankfully,
Funding for women’s health research has nearly doubled in the past decade.
Major public and private initiatives are prioritizing sex-based research like never before.
The FDA is increasingly mandating sex-based data analysis in clinical trials.
More therapies are now being evaluated and approved with women’s unique biology in mind.
Femtech is one of the fastest-growing health sectors.
Startups are driving innovation in menstrual health, fertility, menopause, and chronic conditions affecting women.
Read the Women's Health Access Matters Report
4 episodes
Share
